STAT3 and lung carcinoma: It can inhibit the expression of XIST and the IL-6/STAT3 signaling pathway in cells, thus promoting the expression of miR-let-7c, and the overexpression of miR-let-7c can promote the regulation of lung cancer cells through the IL-6/STAT3 axis.